
Opinion|Videos|August 11, 2026
Emerging Indications for Solriamfetol
Winter explores how solriamfetol's emerging pipeline (ADHD, binge eating disorder, major depressive disorder, shift work disorder) may reshape the future of CNS pharmacology and the pharmacist's evolving role in this space.
Advertisement
Episodes in this series

Winter explores how solriamfetol's emerging pipeline (ADHD, binge eating disorder, major depressive disorder, shift work disorder) may reshape the future of CNS pharmacology and the pharmacist's evolving role in this space.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Inflation Reduction Act and Oncology Drug Pricing: What Pharmacists Need to Know
2
FDA Fast Tracks First-in-Class TNFR2 Antibody as Chemotherapy-Free Strategy for Platinum-Resistant Ovarian Cancer
3
Yes, COVID-19 Is Still a Big Deal. Pharmacy Is the Tip of the Spear (and Needle)
4
Trump Executive Order Recommends Separating MMR Into 3 Shots
5


































































































